Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 4 1

Status

Terminated 1Recruiting 1Completed 1

Sponsor Class

OTHER 3NETWORK 1INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Other hematologic neoplasm 1Other 1Lymphoid 1Gynecologic 1Breast 1

Conditions

Stomatitis 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Ovarian Neoplasms 1Mucositis 1Hyperbilirubinemia 1Folic Acid Deficiency 1Breast Neoplasms 1

Interventions

pembrolizumab 593Cyclophosphamide 539Magnetic Resonance Spectroscopy 527Radiotherapy 506Specimen Handling 504Nivolumab 406Cisplatin 370Carboplatin 360Biopsy 306Blood Specimen Collection 296Radiosurgery 284Paclitaxel 276Surveys and Questionnaires 269Standard of Care 267Gemcitabine 266fludarabine 261Dexamethasone 258Drug Therapy 256Bevacizumab 248venetoclax 247Oxaliplatin 206Rituximab 197Capecitabine 194Radiation 190Fluorouracil 186Ipilimumab 183durvalumab 181Doxorubicin 174atezolizumab 172Etoposide 171

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Folic Acid × 1 year × Clear all
NCT03581773 2026-05-04

DARENCA4

University of Aarhus

Phase 2 Recruiting
100 enrolled
Other

Stomatitis, Mucositis

NCT04024254 2026-03-04

A Study of Serum Folate Levels in Patients Treated With Olaparib

Rush University Medical Center

Phase 4 Completed
10 enrolled 14 charts
BreastGynecologic

Breast Neoplasms, Folic Acid Deficiency, Ovarian Neoplasms

NCT03564678 2025-09-05

Levocarnitine and Vitamin B Complex in Treating PEG-Asparaginase or Inotuzumab Ozogamicin-Induced Hyperbilirubinemia in Patients With Acute Lymphoblastic Leukemia

M.D. Anderson Cancer Center

Phase 2 Terminated
10 enrolled 5 charts
LymphoidOther hematologic neoplasm

Hyperbilirubinemia, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡